Medivolve Inc. — AGM Information 2022

May 25, 2022

==> picture [132 x 89] intentionally omitted <==

MEDIVOLVE INC. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

You are invited to our 2022 annual and special meeting (the “ Meeting ”) of common shareholders of Medivolve Inc. (the “ Corporation ”).

When: June 15, 2022 at 12:00 p.m. (Toronto time)

Where: 198 Davenport Road, Toronto, Ontario M5R 1J2

The purpose of the Meeting is as follows:

1. Financial Statements. Receive and consider the audited financial statements as at and for the fiscal year ended December 31, 2021, together with the report of the auditor thereon.

2. Auditor Appointment. Appoint McGovern Hurley LLP as auditor of the Corporation.

3. Share Consolidation. Consider and pass, with or without variation, a special resolution reapproving the consolidation of the Corporation’s common shares on the basis of up to 15 for 1.

4. Name Change. Consider and pass, with or without variation, a special resolution approving an amendment to the articles of the Corporation to change the name of the Corporation to “Medidoc Inc.”, or such other name as the board of directors of the Corporation, in its sole discretion, deems appropriate, as more fully described in the management information circular dated May 16, 2022 (the “ Circular ”).

5. Elect Directors. Consider and elect the directors for the ensuing year.

6. Other Business. Consider other business as may properly come before the Meeting or any postponement(s) or adjournment(s) thereof.

This notice is accompanied by (i) a form of proxy, (ii) the Circular, and (iii) the audited consolidated financial statements of the Corporation as at and for the fiscal year ended December 31, 2021 and related management’s discussion and analysis of financial condition.

You may vote your shares by proxy if you are unable to attend the Meeting. Please review the enclosed Circular and date, sign and return the enclosed form of proxy to the Corporation’s transfer agent by 12:00 p.m. (Toronto time) on June 13, 2022.

In the event of a postal disruption as a result of a Canada Post labour disruption or other cause, please see “ Voting – Appointment and Revocation of Proxies ” and “ Voting of Proxies – Non-Registered Shareholders ” in the Circular for information on how to obtain and submit a form of proxy or voting information form, as applicable.

The directors of the Corporation have fixed the close of business on May 16, 2022 as the record date, being the date for the determination of the registered holders entitled to notice and to vote at the Meeting and any postponement(s) or adjournments(s) thereof.

1

==> picture [132 x 89] intentionally omitted <==

The Corporation intends to hold the Meeting in person. However, in view of the evolving COVID-19 situation, the Corporation strongly encourages shareholders not to attend the Meeting in person. As always, the Corporation encourages shareholders to vote their common shares prior to the Meeting by following the instructions under the heading "Voting of Proxies" in the accompanying Circular. The Corporation may take additional precautionary measures in relation to the Meeting in response to further developments with the COVID-19 pandemic. In the event it is not possible or advisable to hold the Meeting in person, the Corporation will announce alternative arrangements for the Meeting as promptly as practicable, which may include holding the Meeting entirely by electronic means, telephone or other communication facilities.

DATED at Toronto, Ontario as of the 16[th] day of May, 2022.

BY ORDER OF THE BOARD OF DIRECTORS

“David Preiner”

President and Chief Executive Officer

2